MIRAGEN THERAPEUTICS INC (MGEN)
Institutional ownership reported to the SEC as of Q4 2020, across 9 quarters.
20
Reporting holders
$32.9M
Reported value
0.0%
Held as options
-5
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Logos Global Management LP | $9.0M | 550,000 | 0.78% | new | NEW |
| RA CAPITAL MANAGEMENT, L.P. | $7.4M | 451,932 | 0.10% | new | NEW |
| Point72 Asset Management, L.P. | $7.0M | 426,162 | 0.03% | new | NEW |
| VANGUARD GROUP INC | $2.6M | 160,088 | 0.00% | new | NEW |
| Cormorant Asset Management, LP | $1.5M | 93,126 | 0.04% | new | NEW |
| Soleus Capital Management, L.P. | $1.3M | 81,185 | 0.18% | new | NEW |
| RENAISSANCE TECHNOLOGIES LLC | $878.0K | 53,402 | 0.00% | new | NEW |
| Fairmount Funds Management LLC | $554.0K | 35,092 | 0.20% | new | NEW |
| DRIEHAUS CAPITAL MANAGEMENT LLC | $548.0K | 33,333 | 0.01% | new | NEW |
| BlackRock Inc. | $508.0K | 30,880 | 0.00% | new | NEW |
| SPHERA FUNDS MANAGEMENT LTD. | $502.0K | 30,497 | 0.04% | new | NEW |
| CITADEL ADVISORS LLC | $330.0K | 20,040 | 0.00% | new | NEW |
| GEODE CAPITAL MANAGEMENT, LLC | $257.0K | 15,675 | 0.00% | new | NEW |
| BVF INC/IL | $160.0K | 9,747 | 0.01% | new | NEW |
| Banque Cantonale Vaudoise | $55.0K | 3,333 | 0.00% | new | NEW |
| UBS Group AG | $36.0K | 2,242 | 0.00% | new | NEW |
| Tower Research Capital LLC (TRC) | $23.0K | 1,392 | 0.00% | new | NEW |
| WELLS FARGO & COMPANY/MN | $8.0K | 468 | 0.00% | new | NEW |
| MORGAN STANLEY | $2.0K | 125 | 0.00% | new | NEW |
| ADVISOR GROUP HOLDINGS, INC. | $1.0K | 80 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q4 2020 | 20 | $32.9M | 1,998,799 | 20 | 0 | 0 | 0.0% |
| Q3 2020 | 25 | $8.4M | 10,755,052 | 8 | 5 | 1 | 0.0% |
| Q2 2020 | 28 | $12.5M | 10,761,881 | 8 | 4 | 8 | 4.4% |
| Q1 2020 | 25 | $5.3M | 11,294,205 | 9 | 5 | 4 | 4.2% |
| Q4 2019 | 21 | $4.4M | 9,113,140 | 2 | 2 | 5 | 0.0% |
| Q3 2019 | 31 | $7.9M | 10,867,134 | 3 | 3 | 14 | 0.0% |
| Q2 2019 | 44 | $25.0M | 12,191,074 | 9 | 9 | 14 | 0.0% |
| Q1 2019 | 50 | $36.9M | 13,241,498 | 3 | 17 | 13 | 0.0% |
| Q4 2018 | 55 | $45.2M | 14,900,470 | 2 | 2 | 0 | 0.0% |